Seeing Is Believing
Currently out of the existing stock ratings of Bill Sutherland, 138 are a BUY (89.03%), 17 are a HOLD (10.97%).
Analyst Bill Sutherland, currently employed at BENCHMARK, carries an average stock price target met ratio of 24.49% that have a potential upside of 25.35% achieved within 127 days.
Bill Sutherland’s has documented 304 price targets and ratings displayed on 21 stocks. The coverage is on Healthcare, Industrials sectors.
Most recent stock forecast was given on SEM, Select Medical Holdings at 16-Jul-2024.
Analyst best performing recommendations are on AUGX (AUGMEDIX).
The best stock recommendation documented was for AUGX (AUGMEDIX) at 3/31/2023. The price target of $5 was fulfilled within 88 days with a profit of $3.26 (187.36%) receiving and performance score of 21.29.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
101
$3.4 (3.48%)
101
3 months 1 days ago
1/7 (14.29%)
$9.84 (10.79%)
45
Hold
4 months ago
5/10 (50%)
$12.13 (9.49%)
99
Hold
101
$3.4 (3.48%)
84
11 months 25 days ago
1/3 (33.33%)
$10.16 (11.18%)
28
Hold
101
$3.4 (3.48%)
100
11 months 29 days ago
0/5 (0%)
$10.5 (11.60%)
Hold
98
$0.4 (0.41%)
200
1 years 20 days ago
12/15 (80%)
$6.69 (7.33%)
142
Which stock is Bill Sutherland is most bullish on?
Which stock is Bill Sutherland is most reserved on?
What Year was the first public recommendation made by Bill Sutherland?